- call +1-201-465-4211
- email sales@mrinsights.biz
Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4).
Scope of the Report:
Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition.
This has resulted in a strong need for better therapeutics such as incretin based drugs.
Incretin not only increases the secretion of insulin by acting on pancreatic beta cells, but also inhibits the release of glucagon by acting on the pancreatic alpha cells.
The worldwide market for Incretin-Based Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Incretin-Based Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Johnson & Johnson
Merck & Co
AstraZeneca
Novartis
Eli Lilly and Company
Boehringer Ingelheim
Takeda Pharmaceutical Company
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Glucagon-like peptide-1 receptor (GLP-1) agonists
Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Market Segment by Applications, can be divided into
Oral Drugs
Injectable Drugs
There are 15 Chapters to deeply display the global Incretin-Based Drugs market.
Chapter 1, to describe Incretin-Based Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Incretin-Based Drugs, with sales, revenue, and price of Incretin-Based Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Incretin-Based Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Incretin-Based Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Incretin-Based Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Incretin-Based Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Glucagon-like peptide-1 receptor (GLP-1) agonists
1.2.2 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
1.3 Market Analysis by Applications
1.3.1 Oral Drugs
1.3.2 Injectable Drugs
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Incretin-Based Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Incretin-Based Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck & Co
2.3.1 Business Overview
2.3.2 Incretin-Based Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck & Co Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 AstraZeneca
2.4.1 Business Overview
2.4.2 Incretin-Based Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AstraZeneca Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Incretin-Based Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly and Company
2.6.1 Business Overview
2.6.2 Incretin-Based Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly and Company Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Boehringer Ingelheim
2.7.1 Business Overview
2.7.2 Incretin-Based Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Boehringer Ingelheim Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda Pharmaceutical Company
2.8.1 Business Overview
2.8.2 Incretin-Based Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Incretin-Based Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Incretin-Based Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Incretin-Based Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Incretin-Based Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Incretin-Based Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Incretin-Based Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Incretin-Based Drugs Market Analysis by Regions
4.1 Global Incretin-Based Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Incretin-Based Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Incretin-Based Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Incretin-Based Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Incretin-Based Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Incretin-Based Drugs Sales and Growth Rate (2013-2018)
4.5 South America Incretin-Based Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Incretin-Based Drugs Sales and Growth Rate (2013-2018)
5 North America Incretin-Based Drugs by Countries
5.1 North America Incretin-Based Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Incretin-Based Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Incretin-Based Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Incretin-Based Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Incretin-Based Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Incretin-Based Drugs Sales and Growth Rate (2013-2018)
6 Europe Incretin-Based Drugs by Countries
6.1 Europe Incretin-Based Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Incretin-Based Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Incretin-Based Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Incretin-Based Drugs Sales and Growth Rate (2013-2018)
6.3 UK Incretin-Based Drugs Sales and Growth Rate (2013-2018)
6.4 France Incretin-Based Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Incretin-Based Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Incretin-Based Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Incretin-Based Drugs by Countries
7.1 Asia-Pacific Incretin-Based Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Incretin-Based Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Incretin-Based Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Incretin-Based Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Incretin-Based Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Incretin-Based Drugs Sales and Growth Rate (2013-2018)
7.5 India Incretin-Based Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Incretin-Based Drugs Sales and Growth Rate (2013-2018)
8 South America Incretin-Based Drugs by Countries
8.1 South America Incretin-Based Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Incretin-Based Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Incretin-Based Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Incretin-Based Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Incretin-Based Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Incretin-Based Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Incretin-Based Drugs by Countries
9.1 Middle East and Africa Incretin-Based Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Incretin-Based Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Incretin-Based Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Incretin-Based Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Incretin-Based Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Incretin-Based Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Incretin-Based Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Incretin-Based Drugs Sales and Growth Rate (2013-2018)
10 Global Incretin-Based Drugs Market Segment by Type
10.1 Global Incretin-Based Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Incretin-Based Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Incretin-Based Drugs Revenue and Market Share by Type (2013-2018)
10.2 Glucagon-like peptide-1 receptor (GLP-1) agonists Sales Growth and Price
10.2.1 Global Glucagon-like peptide-1 receptor (GLP-1) agonists Sales Growth (2013-2018)
10.2.2 Global Glucagon-like peptide-1 receptor (GLP-1) agonists Price (2013-2018)
10.3 Dipeptidyl Peptidase-4 (DPP-4) inhibitors Sales Growth and Price
10.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) inhibitors Sales Growth (2013-2018)
10.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) inhibitors Price (2013-2018)
11 Global Incretin-Based Drugs Market Segment by Application
11.1 Global Incretin-Based Drugs Sales Market Share by Application (2013-2018)
11.2 Oral Drugs Sales Growth (2013-2018)
11.3 Injectable Drugs Sales Growth (2013-2018)
12 Incretin-Based Drugs Market Forecast (2018-2023)
12.1 Global Incretin-Based Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Incretin-Based Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Incretin-Based Drugs Market Forecast (2018-2023)
12.2.2 Europe Incretin-Based Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Incretin-Based Drugs Market Forecast (2018-2023)
12.2.4 South America Incretin-Based Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Incretin-Based Drugs Market Forecast (2018-2023)
12.3 Incretin-Based Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Incretin-Based Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Incretin-Based Drugs Market Share Forecast by Type (2018-2023)
12.4 Incretin-Based Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Incretin-Based Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Incretin-Based Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Incretin-Based Drugs Picture
Table Product Specifications of Incretin-Based Drugs
Figure Global Sales Market Share of Incretin-Based Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
